<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38532465</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1479-5876</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>26</Day></PubDate></JournalIssue><Title>Journal of translational medicine</Title><ISOAbbreviation>J Transl Med</ISOAbbreviation></Journal><ArticleTitle>Bulk RNA sequencing for analysis of post COVID-19 condition in adolescents and young adults.</ArticleTitle><Pagination><StartPage>312</StartPage><MedlinePgn>312</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">312</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12967-024-05117-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">Post COVID-19 condition (PCC) is a complication of SARS-COV-2 infection and can lead to long-term disability.</AbstractText><AbstractText Label="METHODS">The present study was designed to analyse the gene expression patterns of PCC through bulk RNA sequencing of whole blood and to explore the potential molecular mechanisms of PCC. Whole blood was collected from 80 participants enrolled in a prospective cohort study following SARS-CoV-2 infected and non-infected individuals for 6&#xa0;months after recruitment and was used for bulk RNA sequencing. Identification of differentially expressed genes (DEG), pathway enrichment and immune cell deconvolution was performed to explore potential biological pathways involved in PCC.</AbstractText><AbstractText Label="RESULTS">We have found 13 differentially expressed genes associated with PCC. Enriched pathways were related to interferon-signalling and anti-viral immune processes.</AbstractText><AbstractText Label="CONCLUSION">The PCC transcriptome is characterized by a modest overexpression of interferon-stimulated genes, pointing to a subtle ongoing inflammatory response.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sommen</LastName><ForeName>Silke Lauren</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Akershus University Hospital, L&#xf8;renskog, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Zhi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Oslo Centre for Biostatistics and Epidemiology (OCBE), Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Segtnan</LastName><ForeName>Sunniva</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stiansen-Sonerud</LastName><ForeName>Tonje</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Akershus University Hospital, L&#xf8;renskog, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Molecular Biology (EpiGen), University of Oslo and Akershus University Hospital, L&#xf8;renskog, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Selvakumar</LastName><ForeName>Joel</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Akershus University Hospital, L&#xf8;renskog, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beier Havdal</LastName><ForeName>Lise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Akershus University Hospital, L&#xf8;renskog, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gjerstad</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Behavioural Sciences, Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wyller</LastName><ForeName>Vegard Bruun Bratholm</ForeName><Initials>VBB</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Akershus University Hospital, L&#xf8;renskog, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lund Berven</LastName><ForeName>Lise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Akershus University Hospital, L&#xf8;renskog, Norway. lise.lund-berven@medisin.uio.no.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>302079</GrantID><Agency>Norges Forskningsr&#xe5;d</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Transl Med</MedlineTA><NlmUniqueID>101190741</NlmUniqueID><ISSNLinking>1479-5876</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9008-11-1</RegistryNumber><NameOfSubstance UI="D007372">Interferons</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017423" MajorTopicYN="N">Sequence Analysis, RNA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007372" MajorTopicYN="N">Interferons</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adolescent</Keyword><Keyword MajorTopicYN="N">Child</Keyword><Keyword MajorTopicYN="N">Immunology</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post COVID-19 condition</Keyword><Keyword MajorTopicYN="N">RNA sequencing</Keyword><Keyword MajorTopicYN="N">Transcriptomics</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>27</Day><Hour>1</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38532465</ArticleId><ArticleId IdType="pmc">PMC10964710</ArticleId><ArticleId IdType="doi">10.1186/s12967-024-05117-7</ArticleId><ArticleId IdType="pii">10.1186/s12967-024-05117-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sandler CX, Wyller VBB, Moss-Morris R, Buchwald D, Crawley E, Hautvast J, et al. Long COVID and post-infective fatigue syndrome: a review. Open Forum Infect Dis. 2021;8(10):ofab440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8496765</ArticleId><ArticleId IdType="pubmed">34631916</ArticleId></ArticleIdList></Reference><Reference><Citation>Behnood SA, Shafran R, Bennett SD, Zhang AXD, O'Mahoney LL, Stephenson TJ, et al. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: a meta-analysis of controlled and uncontrolled studies. J Infect. 2022;84(2):158&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8604800</ArticleId><ArticleId IdType="pubmed">34813820</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P, Pittet LF, Curtis N. How common is long COVID in children and adolescents? Pediatr Infect Dis J. 2021;40(12):e482&#x2013;e487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575095</ArticleId><ArticleId IdType="pubmed">34870392</ArticleId></ArticleIdList></Reference><Reference><Citation>Mogensen I, Ekstrom S, Hallberg J, Georgelis A, Melen E, Bergstrom A, et al. Post COVID-19 symptoms are common, also among young adults in the general population. Sci Rep. 2023;13(1):11300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10338459</ArticleId><ArticleId IdType="pubmed">37438424</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto Pereira SM, Nugawela MD, Rojas NK, Shafran R, McOwat K, Simmons R, et al. Post-COVID-19 condition at 6 months and COVID-19 vaccination in non-hospitalised children and young people. Arch Dis Child. 2023;108(4):289&#x2013;295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10086284</ArticleId><ArticleId IdType="pubmed">36599625</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Ayuzo Del Valle NC, Perelman C, Sepulveda R, Rebolledo PA, et al. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep. 2022;12(1):9950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>Behnood S, Newlands F, O'Mahoney L, Haghighat Ghahfarokhi M, Muhid MZ, Dudley J, et al. Persistent symptoms are associated with long term effects of COVID-19 among children and young people: Results from a systematic review and meta-analysis of controlled studies. PLoS ONE. 2023;18(12):e0293600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10754445</ArticleId><ArticleId IdType="pubmed">38153928</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Pinto Pereira SM, Nugawela MD, McOwat K, Simmons R, Chalder T, et al. Long COVID-six months of prospective follow-up of changes in symptom profiles of non-hospitalised children and young people after SARS-CoV-2 testing: A national matched cohort study (The CLoCk) study. PLoS ONE. 2023;18(3):e0277704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9987792</ArticleId><ArticleId IdType="pubmed">36877677</ArticleId></ArticleIdList></Reference><Reference><Citation>Zavala M, Ireland G, Amin-Chowdhury Z, Ramsay ME, Ladhani SN. Acute and persistent symptoms in children with polymerase chain reaction (PCR)-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection compared with test-negative children in england: active, prospective. Natl Surveill Clin Infect Dis. 2022;75(1):e191&#x2013;e200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8767867</ArticleId><ArticleId IdType="pubmed">34849658</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, Wood J, Jaycox JR, Dhodapkar RM, Lu P, Gehlhausen JR, et al. Distinguishing features of long COVID identified through immune profiling. Nature. 2023;623(7985):139&#x2013;148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):210&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881&#x2013;95 e20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591(7851):639&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z, Senussi Y, Manickas-Hill Z, Yu XG, Li JZ, Alter G, et al. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin Infect Dis. 2023;76(3):e487&#x2013;e490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deveau TM, Munter SE, Ryder D, Buck A, Beck-Engeser G, et al. Chronic viral coinfections differentially affect the likelihood of developing long COVID. J Clin Invest. 2023 doi: 10.1172/JCI163669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI163669</ArticleId><ArticleId IdType="pmc">PMC9888380</ArticleId><ArticleId IdType="pubmed">36454631</ArticleId></ArticleIdList></Reference><Reference><Citation>Son K, Jamil R, Chowdhury A, Mukherjee M, Venegas C, Miyasaki K, et al. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms. Eur Respir J. 2023;61(1):2200970.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund Berven L, Selvakumar J, Havdal L, Stiansen-Sonerud T, Einvik G, Leegaard TM, et al. Inflammatory markers, pulmonary function, and clinical symptoms in acute COVID-19 among non-hospitalized adolescents and young adults. Front Immunol. 2022;13:837288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8864121</ArticleId><ArticleId IdType="pubmed">35222429</ArticleId></ArticleIdList></Reference><Reference><Citation>Havdal LB, Berven LL, Selvakumar J, Stiansen-Sonerud T, Leegaard TM, Tjade T, et al. Neurological involvement in COVID-19 among non-hospitalized adolescents and young adults. Front Neurol. 2022;13:915712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9257204</ArticleId><ArticleId IdType="pubmed">35812102</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvakumar J, Havdal LB, Drevvatne M, Brodwall EM, Lund Berven L, Stiansen-Sonerud T, et al. Prevalence and characteristics associated with post-COVID-19 condition among nonhospitalized adolescents and young adults. JAMA Netw Open. 2023;6(3):e235763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10064252</ArticleId><ArticleId IdType="pubmed">36995712</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommen SL, Havdal LB, Selvakumar J, Einvik G, Leegaard TM, Lund-Johansen F, et al. Inflammatory markers and pulmonary function in adolescents and young adults 6 months after mild COVID-19. Front Immunol. 2022;13:1081718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9853911</ArticleId><ArticleId IdType="pubmed">36685555</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, et al. Development of a fatigue scale. J Psychosom Res. 1993;37(2):147&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">8463991</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Sunnquist M. The development of the DePaul symptom questionnaire: original, expanded, brief, and pediatric versions. Front Pediatr. 2018;6:330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6232226</ArticleId><ArticleId IdType="pubmed">30460215</ArticleId></ArticleIdList></Reference><Reference><Citation>Varni JW, Burwinkle TM, Seid M, Skarr D. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr. 2003;3(6):329&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pubmed">14616041</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott J, Whitaker M, Bodinier B, Eales O, Riley S, Ward H, et al. Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people. PLoS Med. 2021;18(9):e1003777.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478234</ArticleId><ArticleId IdType="pubmed">34582457</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, Condition WHOCCDWGoP-C-. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102-e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994; 121(12):953&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki YI, Taguchi K, Anzawa H, Kawashima J, Ishida N, Otuki A, et al. Whole blood transcriptome analysis for age- and gender-specific gene expression profiling in Japanese individuals. J Biochem. 2024 doi: 10.1093/jb/mvae008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jb/mvae008</ArticleId><ArticleId IdType="pubmed">38268329</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie CE, Lowe DJ, McAuley A, Winter AJ, Mills NL, Black C, et al. Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study. Nat Commun. 2022;13(1):5663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9556711</ArticleId><ArticleId IdType="pubmed">36224173</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. 1995;57:289&#x2013;300.</Citation></Reference><Reference><Citation>Zhang B, Kirov S, Snoddy J. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 2005;33(Web Server issue):W741&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1160236</ArticleId><ArticleId IdType="pubmed">15980575</ArticleId></ArticleIdList></Reference><Reference><Citation>Puig RR, Boddie P, Khan A, Castro-Mondragon JA, Mathelier A. UniBind: maps of high-confidence direct TF-DNA interactions across nine species. BMC Genomics. 2021;22(1):482.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8236138</ArticleId><ArticleId IdType="pubmed">34174819</ArticleId></ArticleIdList></Reference><Reference><Citation>Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37(7):773&#x2013;782.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6610714</ArticleId><ArticleId IdType="pubmed">31061481</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier M. DirichletReg: Dirichlet Regression for Compositional Data in R. Research Report Series, Department of Statistics and Mathematics, 125. 2014;WU Vienna University of Economics and Business, Vienna.</Citation></Reference><Reference><Citation>Liefferinckx C, De Greve Z, Toubeau JF, Peree H, Quertinmont E, Tafciu V, et al. New approach to determine the healthy immune variations by combining clustering methods. Sci Rep. 2021;11(1):8917.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8076194</ArticleId><ArticleId IdType="pubmed">33903641</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon N, Friedman, J., Hastie, T. A blockwise descent algorithm for group-penalized multiresponse and multinomial regression. arXiv. 2013;arXiv:1311.6529.</Citation></Reference><Reference><Citation>Chin K-CCP. Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalo- virus. Proc Natl Acad Sci U S A. 2001;98:15125&#x2013;15130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC64994</ArticleId><ArticleId IdType="pubmed">11752458</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J, Ghosh A, Sarkar SN. OASL-a new player in controlling antiviral innate immunity. Curr Opin Virol. 2015;12:15&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4470762</ArticleId><ArticleId IdType="pubmed">25676874</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabbani MA, Ribaudo M, Guo JT, Barik S. Identification of interferon-stimulated gene proteins that inhibit human parainfluenza virus type 3. J Virol. 2016;90(24):11145&#x2013;11156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5126372</ArticleId><ArticleId IdType="pubmed">27707917</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi HX, Yang K, Liu X, Liu XY, Wei B, Shan YF, et al. Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification. Mol Cell Biol. 2010;30(10):2424&#x2013;2436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2863703</ArticleId><ArticleId IdType="pubmed">20308324</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell JA, Lenschow DJ. Emerging roles for immunomodulatory functions of free ISG15. J Interferon Cytokine Res. 2013;33(12):728&#x2013;738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3868375</ArticleId><ArticleId IdType="pubmed">24010825</ArticleId></ArticleIdList></Reference><Reference><Citation>Villamayor L, Rivero V, Lopez-Garcia D, Topham DJ, Martinez-Sobrido L, Nogales A, et al. Interferon alpha inducible protein 6 is a negative regulator of innate immune responses by modulating RIG-I activation. Front Immunol. 2023;14:1105309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9923010</ArticleId><ArticleId IdType="pubmed">36793726</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman I, Sanchez AC, Davies J, Rzeniewicz K, Abukscem S, Joachim J, et al. L-selectin regulates human neutrophil transendothelial migration. J Cell Sci. 2022 doi: 10.1242/jcs.260658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.260658</ArticleId><ArticleId IdType="pubmed">36259426</ArticleId></ArticleIdList></Reference><Reference><Citation>McKellar J, Arnaud-Arnould M, Chaloin L, Tauziet M, Arpin-Andre C, Pourcelot O, et al. An evolutionarily conserved N-terminal leucine is essential for MX1 GTPase antiviral activity against different families of RNA viruses. J Biol Chem. 2023;299(1):102747.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9808005</ArticleId><ArticleId IdType="pubmed">36436557</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo W, Zhang J, Liang L, Wang G, Li Q, Zhu P, et al. Phospholipid scramblase 1 interacts with influenza A virus NP, impairing its nuclear import and thereby suppressing virus replication. PLoS Pathog. 2018;14(1):e1006851.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5792031</ArticleId><ArticleId IdType="pubmed">29352288</ArticleId></ArticleIdList></Reference><Reference><Citation>(KEGG) KEGaG. 2023.</Citation></Reference><Reference><Citation>Tolomeo M, Cavalli A, Cascio A. STAT1 and its crucial role in the control of viral infections. Int J Mol Sci. 2022;23(8):4095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9028532</ArticleId><ArticleId IdType="pubmed">35456913</ArticleId></ArticleIdList></Reference><Reference><Citation>Steen HC, Gamero AM. STAT2 phosphorylation and signaling. JAKSTAT. 2013;2(4):e25790.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3876438</ArticleId><ArticleId IdType="pubmed">24416652</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Tang YD, Zheng C. Revisiting IRF1-mediated antiviral innate immunity. Cytokine Growth Factor Rev. 2022;64:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">35090813</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA, et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. 2023;329(22):1934&#x2013;1946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivetic A, Hoskins Green HL, Hart SJ. L-selectin: a major regulator of leukocyte adhesion. Migr Signal Front Immunol. 2019;10:1068.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6527602</ArticleId><ArticleId IdType="pubmed">31139190</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesteberg KE, Araya P, Waugh KA, Chauhan L, Espinosa JM, Beckham JD. Severely ill and high-risk COVID-19 patients exhibit increased peripheral circulation of CD62L+ and perforin+ T cells. Front Immunol. 2023;14:1113932.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9932815</ArticleId><ArticleId IdType="pubmed">36817450</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MW SA, J&#xf8;rgensen T, &#xd8;rnb&#xf8;l E, Meinertz Dantoft T, Eliasen M, Wisbech Carstensen T, Falgaard Eplov Lene, Fink Per. Prevalence of functional somatic syndromes and bodily distress syndrome in the Danish population: the DanFunD study. Sandinavian Journal of Public Health. 2020; 48(5):567&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">31409218</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta-Ampudia Y, Monsalve DM, Rojas M, Rodriguez Y, Zapata E, Ramirez-Santana C, et al. Persistent autoimmune activation and proinflammatory state in post-coronavirus disease 2019 syndrome. J Infect Dis. 2022;225(12):2155&#x2013;2162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903340</ArticleId><ArticleId IdType="pubmed">35079804</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejerina F, Catalan P, Rodriguez-Grande C, Adan J, Rodriguez-Gonzalez C, Munoz P, et al. Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. BMC Infect Dis. 2022;22(1):211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8892394</ArticleId><ArticleId IdType="pubmed">35240997</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A, Koch R, Jukic A, Pfister A, Meyer M, Rossler A, et al. Postacute COVID-19 is Characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology. 2022;163(2):495&#x2013;506 e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Craddock V, Mahajan A, Spikes L, Krishnamachary B, Ram AK, Kumar A, et al. Persistent circulation of soluble and extracellular vesicle-linked Spike protein in individuals with postacute sequelae of COVID-19. J Med Virol. 2023;95(2):e28568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10048846</ArticleId><ArticleId IdType="pubmed">36756925</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of long COVID prevalence and its relationship to epstein-barr virus reactivation. Pathogens. 2021;10(6):763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandy Z, da Costa IC, Schmidt CK. More than Meets the ISG15: Emerging Roles in the DNA Damage Response and Beyond. Biomolecules. 2020;10(11):1557.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7698331</ArticleId><ArticleId IdType="pubmed">33203188</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med. 2003;197(6):711&#x2013;723.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2193846</ArticleId><ArticleId IdType="pubmed">12642603</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff MC, Bonham KS, Anam FA, Walker TA, Faliti CE, Ishii Y, et al. Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID. Nat Commun. 2023;14(1):4201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10349085</ArticleId><ArticleId IdType="pubmed">37452024</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna BA, Lim EY, Metaxaki M, Jackson S, Mactavous L, N BioResource et al. Spontaneous, persistent, T cell-dependent IFN-gamma release in patients who progress to long Covid. Sci Adv. 2024;10(8):9379.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10881041</ArticleId><ArticleId IdType="pubmed">38381822</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere JJSR, Pryce KD, Zazhytska M, Oishi K, Golynker I, Panis M, Zimering J, Horiuchi S, Hoagland DA, M&#xf8;ller R, Ruiz A, Kodra A, Overdevest JB, Canoll PD, Borczuk AC, Chandar V, Bram Y, Schwartz R, Lomvardas S, Zachariou V, tenOever BR. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery. Sci Transl Med. 2022 doi: 10.1126/scitranslmed.abq3059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abq3059</ArticleId><ArticleId IdType="pmc">PMC9210449</ArticleId><ArticleId IdType="pubmed">35857629</ArticleId></ArticleIdList></Reference><Reference><Citation>Berentschot JC, Drexhage HA, Aynekulu Mersha DG, Wijkhuijs AJM, GeurtsvanKessel CH, Koopmans MPG, et al. Immunological profiling in long COVID: overall low grade inflammation and T-lymphocyte senescence and increased monocyte activation correlating with increasing fatigue severity. Front Immunol. 2023;14:1254899.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10597688</ArticleId><ArticleId IdType="pubmed">37881427</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan FJ, Hope CM, Masavuli MG, Lynn MA, Mekonnen ZA, Yeow AEL, et al. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Med. 2022;20(1):26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin K, Peluso MJ, Luo X, Thomas R, Shin MG, Neidleman J, et al. Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2. bioRxiv. 2023;21:148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10834368</ArticleId><ArticleId IdType="pubmed">38212464</ArticleId></ArticleIdList></Reference><Reference><Citation>Sneller MC, Liang CJ, Marques AR, Chung JY, Shanbhag SM, Fontana JR, et al. A longitudinal study of COVID-19 sequelae and Immunity: baseline findings. Ann Intern Med. 2022;175(7):969&#x2013;979.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9128805</ArticleId><ArticleId IdType="pubmed">35605238</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong AC, Devason AS, Umana IC, Cox TO, Dohnalova L, Litichevskiy L, et al. Serotonin reduction in post-acute sequelae of viral infection. Cell. 2023;186(22):4851&#x2013;67 e20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11227373</ArticleId><ArticleId IdType="pubmed">37848036</ArticleId></ArticleIdList></Reference><Reference><Citation>Littlefield KM, Watson RO, Schneider JM, Neff CP, Yamada E, Zhang M, et al. SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PLoS Pathog. 2022;18(5):e1010359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9176759</ArticleId><ArticleId IdType="pubmed">35617421</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene C, Connolly R, Brennan D, Laffan A, O'Keeffe E, Zaporojan L, et al. Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci. 2024;382:727.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10917679</ArticleId><ArticleId IdType="pubmed">38388736</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole SW. Human social genomics. PLoS Genet. 2014;10(8):e1004601.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4148225</ArticleId><ArticleId IdType="pubmed">25166010</ArticleId></ArticleIdList></Reference><Reference><Citation>Raijmakers RPH, Jansen AFM, Keijmel SP, Schoffelen T, Scholzen A, van der Meer JWM, et al. Interferon-gamma and CXCL10 responses related to complaints in patients with Q fever fatigue syndrome. Eur J Clin Microbiol Infect Dis. 2018;37(7):1385&#x2013;1391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6015096</ArticleId><ArticleId IdType="pubmed">29804281</ArticleId></ArticleIdList></Reference><Reference><Citation>Metselaar PI, Mendoza-Maldonado L, Li Yim AYF, Abarkan I, Henneman P, Te Velde AA, et al. Recursive ensemble feature selection provides a robust mRNA expression signature for myalgic encephalomyelitis/chronic fatigue syndrome. Sci Rep. 2021;11(1):4541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7907358</ArticleId><ArticleId IdType="pubmed">33633136</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya JG, Holmes TH, Anderson JN, Maecker HT, Rosenberg-Hasson Y, Valencia IJ, et al. Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc Natl Acad Sci U S A. 2017;114(34):E7150&#x2013;E7158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5576836</ArticleId><ArticleId IdType="pubmed">28760971</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr JR, Petty R, Burke B, Gough J, Fear D, Sinclair LI, et al. Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J Infect Dis. 2008;197(8):1171&#x2013;1184.</Citation><ArticleIdList><ArticleId IdType="pubmed">18462164</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen CB, Alsoe L, Lindvall JM, Sulheim D, Fagermoen E, Winger A, et al. Whole blood gene expression in adolescent chronic fatigue syndrome: an exploratory cross-sectional study suggesting altered B cell differentiation and survival. J Transl Med. 2017;15(1):102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5426002</ArticleId><ArticleId IdType="pubmed">28494812</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen CB, Kumar S, Zucknick M, Kristensen VN, Gjerstad J, Nilsen H, et al. Associations between clinical symptoms, plasma norepinephrine and deregulated immune gene networks in subgroups of adolescent with chronic fatigue syndrome. Brain Behav Immun. 2019;76:82&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">30419269</ArticleId></ArticleIdList></Reference><Reference><Citation>Galbraith S, Cameron B, Li H, Lau D, Vollmer-Conna U, Lloyd AR. Peripheral blood gene expression in postinfective fatigue syndrome following from three different triggering infections. J Infect Dis. 2011;204(10):1632&#x2013;1640.</Citation><ArticleIdList><ArticleId IdType="pubmed">21964398</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xfc;ttner M, Ostner J, M&#xfc;ller CL, Theis FJ, Schubert B. scCODA is a Bayesian model for compositional single-cell data analysis. Nat Commun. 2021;12(1):6876. doi: 10.1038/s41467-021-27150-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27150-6</ArticleId><ArticleId IdType="pmc">PMC8616929</ArticleId><ArticleId IdType="pubmed">34824236</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>